Detalles de la búsqueda
1.
Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
Int J Cancer
; 122(4): 785-90, 2008 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17957790
2.
Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer.
J Clin Endocrinol Metab
; 91(9): 3667-70, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16772349
3.
An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinases.
J Clin Endocrinol Metab
; 91(10): 4070-6, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16849418
4.
Regulation of inhibitors of differentiation family proteins by thyroid-stimulating hormone in FRTL-5 thyroid cells.
J Korean Med Sci
; 23(2): 262-9, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18437010
5.
Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma.
Am J Clin Oncol
; 30(1): 63-8, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17278897
6.
Lymphocytic hypophysitis with diabetes insipidus: improvement by methylprednisolone pulse therapy.
Korean J Intern Med
; 19(3): 189-92, 2004 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15481611
Resultados
1 -
6
de 6
1
Próxima >
>>